Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.
about
The emerging roles of human tissue kallikreins in cancerA new method to assay protease based on amyloid misfolding: application to prostate cancer diagnosis using a panel of proteases biomarkersStructure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity.Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates.Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.Novel peptide inhibitors of human kallikrein 2.Protease specificity determination by using cellular libraries of peptide substrates (CLiPS).Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate.Substrate specificity of human kallikreins 1 and 6 determined by phage display.Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.High throughput substrate phage display for protease profilingThe extended cleavage specificity of human thrombin.Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).Activation and enzymatic characterization of recombinant human kallikrein 8.A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.The kallikrein world: an update on the human tissue kallikreins.Kallikreins - The melting pot of activity and functionDevelopment of peptides specifically modulating the activity of KLK2 and KLK3.Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.Unleashing the therapeutic potential of human kallikrein-related serine proteases.Propeptides as modulators of functional activity of proteases.Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides.Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer
P2860
Q28290701-97E9FDDA-8DC8-4CC4-8510-0776E7563311Q30437769-2489053E-7049-457A-83B7-7D55C89CFBC4Q30605285-F99179B9-5863-4F57-B704-D9AE2CD6B0CFQ31036435-82C3470A-1936-4039-BC6C-2B4E676F071CQ31161649-9D46BFF3-F271-43E4-8BC7-C2A4B5747F0EQ33235991-2D85777F-DC0A-4EB3-9A37-FAD06ADF1595Q33242138-403D1812-7962-46C4-B755-66094C7B3B12Q33274790-4A0AD884-9589-407C-8D3C-611F477F030FQ33325124-25E87A4C-ABF5-48F3-B485-7A5BC3ACF6AAQ33382170-28D53D96-8BBB-4E5C-8512-B31D94ADC0E0Q33432032-D85B0CC4-349E-4866-954A-87A4A4FD7AEBQ34181932-3AF436B6-2569-437D-A2F0-BE48492A24E1Q34457491-FFB78569-0D4F-4A42-9659-53E70C6227EEQ34541917-B0A588FA-29C6-4C27-8F67-6CE825AD3873Q36442339-BBD77F89-E2CD-4A5D-9750-008DA7D62436Q36519354-EA24E47A-E5AB-4E6E-BCB9-A7BC35F56D33Q36563056-44A14A14-471B-48B8-AB05-4E5617A86A37Q37216674-87FCC5BC-AFC0-4C10-B878-A2DB5606CDC1Q37290033-F4FFB208-3795-4C42-A840-A2D35E8A98B5Q37453804-E5033C1A-E410-4AC7-B5F2-679CD2BC3AF8Q38188878-504877A3-6082-44A7-8FB4-DD85B89EC5FCQ38362486-85AB0A4D-2D02-4789-910C-3A07B43B39F2Q38472448-A9EBBE40-96B3-42EC-8CDD-C927B0A7E4DDQ38868768-B6DE1F62-6F00-43F5-BF8B-283ACBC6D55CQ43151753-4E0AB84E-9529-45DE-AFAD-73CA979BC878Q57940964-F6EB8BED-C4AD-4818-9729-E13397642F3A
P2860
Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Substrate specificity of human ...... d by phage display technology.
@ast
Substrate specificity of human ...... d by phage display technology.
@en
type
label
Substrate specificity of human ...... d by phage display technology.
@ast
Substrate specificity of human ...... d by phage display technology.
@en
prefLabel
Substrate specificity of human ...... d by phage display technology.
@ast
Substrate specificity of human ...... d by phage display technology.
@en
P2093
P2860
P1433
P1476
Substrate specificity of human ...... d by phage display technology.
@en
P2093
Christian M Gygi
David Deperthes
Hans-Jurg Leisinger
Jair Ribeiro Chagas
Jean-Pierre Mach
Sylvain M Cloutier
P2860
P304
P356
10.1046/J.1432-1033.2002.02960.X
P407
P577
2002-06-01T00:00:00Z